Emily Olsen

The Oura Ring Gen 3
By  Emily Olsen 12:35 pm May 10, 2023
Oura said the deal could provide new opportunities in payments and data security.
Businesspeople shaking hands.
By  Emily Olsen 12:36 pm May 9, 2023
The startup plans to use AI-backed retinal imaging to find early signs of disease based on tech from Australian company Eyetelligence.
A person unboxing a Cue test.
By  Emily Olsen 10:49 am May 9, 2023
In a letter to employees, CEO Ayub Khattak said the diagnostics company's new initiatives are "progressing well but are still early in terms of revenue generation."
A person talking to a provider via a video call.
By  Emily Olsen 12:11 pm May 8, 2023
According to an audit by the Office of the Inspector General, Medicare improperly paid for $580 million of psychotherapy care, including $348 million of telehealth services, during the first year of the COVID-19 public health emergency.
A doctor helping set up a patient's smartwatch.
By  Emily Olsen 10:29 am May 5, 2023
Simon-Kucher's Jan Bordon and Kay Schultze discuss how to encourage uptake for digital health products.
A person talking to a provider via a video chat on a laptop
By  Emily Olsen 12:11 pm May 4, 2023
The company reported a larger net loss in the first quarter that included a $330.3 million noncash goodwill impairment charge.
The Minuteful Kidney test
By  Emily Olsen 02:34 pm May 3, 2023
The company also laid off workers in the U.K. and Israel as it shifts focus to the U.S. market.
Casana's Heart Seat
By  Emily Olsen 11:48 am May 3, 2023
The startup plans to file with the FDA to add other monitoring abilities and to introduce the product later this year.
A close-up of a person wearing a smartwatch.
By  Emily Olsen 12:46 pm May 2, 2023
The jury was unable to reach a verdict in the case related to the Apple Watch's health monitoring capabilities.
A doctor looking at a mammogram.
By  Emily Olsen 12:01 pm May 1, 2023
The group who received an interactive DVD and patient navigation services delivered by phone was nearly six times more likely to be up-to-date on breast, cervical and colorectal cancer screenings compared with a cohort who received usual care.